immunoGlobe GmbH成立于1997年，主要业务包括：1）生产研究用蛋白（特别关注信号转导及细胞骨架）；2）对学术机构提供的优良抗体进行商业化；3）提供定制的多克隆抗体生产和纯化。

Our Mission is to supply the Scientific Community with affordable high quality research antibodies and reagents. Towards this goal we are pursuing three major fields, since 1997:

Manufacturing of novel research antibodies (with a focus on signal transduction and the cytoskeleton). More than 50% of the still limited but constantly expanding product portfolio are unique research antibodies available from no other commercial source.

Commercialization of well characterized and established antibodies developed and licensed by our university partners. immunoGlobe® takes over packing, documentation, marketing, and distribution of the products. The company especially benefits also from the marketing activities of its world-wide distributors.

Production & affinity purification of polyclonal custom antibodies (antibody services). imunoGlobe has been one of the first service providers to offer fractional affinity purification with multiple columns! Based on sophisticated purification strategies, our special focus is on the generation of antibodies directed against modifications.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Biothema品牌。

Biothema是一家专注于酶学和临床诊断的公司，提供高质量的酶制剂和生物化学试剂，广泛应用于临床诊断、食品检测和生物研究。Biothema公司采用先进的生产和纯化技术，确保酶制剂的高纯度和高活性；产品广泛应用于临床诊断、食品检测和生物研究；提供灵活的定制酶制剂和试剂开发服务，满足客户需求。

Biothema公司主要产品与服务包括：

（1）酶制剂：提供多种高纯度的酶制剂，包括氧化酶、脱氢酶和过氧化物酶。

（2）临床诊断试剂：提供用于临床诊断的试剂盒，包括血糖、胆固醇和乳酸检测试剂盒。

（3）生物化学试剂；提供多种生物化学试剂，用于食品检测、环境监测和生物研究。

（4）定制服务：根据客户需求，提供定制化的酶制剂和试剂开发服务。

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.